Sun Pharma, Teva to settle patent suit tied to acid-reflux med for $2.15B

06/13/2013 | Reuters

Teva Pharmaceutical Industries and Sun Pharmaceutical Industries agreed to settle a patent-infringement lawsuit connected to Pfizer and Takeda Pharmaceutical's acid-reflux treatment Protonix for $2.15 billion. The two makers of generic drugs are accused of marketing a copy of an existing treatment with unexpired patents. "It is an important milestone, setting a 'book-end' case for the industry," said Bernstein Research analyst Aaron Gal. "It will serve to encourage patent settlements."

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ